NCT05084755View on ClinicalTrials.gov

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

September 16, 2022

Study Completion Date

September 16, 2022

Conditions
Prevention of Infectious Disease Caused by SARS-CoV-2
Trial Locations (3)

Unknown

Research Site, Akita

Research Site, Ibaraki

Research Site, Shizuoka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY